United Therapeutics (UTHR) Tops Q2 EPS by 67c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $591.20 -0.28%
Revenue Growth %: -1.8%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Revenue Growth %: -1.8%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $5.24, $0.67 better than the analyst estimate of $4.57. Revenue for the quarter came in at $596.5 million versus the consensus estimate of $524.18 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orion Marine Group (ORN) Tops Q3 EPS by 3c ; Offers Guidance
- National Research Corporation (NRC) Reports In-Line Q3 EPS
- The Ensign Group (ENSG) Tops Q3 EPS by 6c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
